Detailansicht

Wissensnetz

Person

Caner Süsal

Arzt

Name	Caner Süsal
Ort	Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Variante	Caner Suesal C. Süsald C. Süsal
Beziehung	Universität Heidelberg. Institut für Immunologie und Serologie Collaborative Transplant Study
Weitere Angaben	Oberarzt, Leiter des Antikörperlabors, Chirurgische Klinik, Universitätsklinikum Heidelberg
Datensatztyp	Person
GND-Nummer	102648037X
Datensatz-ID	102648037X
Beteiligt an alle anzeigen Risk of cellular or antibody-mediated rejection in pediatric kidney transplant recipients with BK polyomavirus replication—an international CERTAIN registry study Incidence, risk factors, management strategies, and outcomes of antibody-mediated rejection in pediatric kidney transplant recipients—a multicenter analysis of the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN) Maternal versus paternal living kidney transplant donation is associated with lower rejection in young pediatric recipients: A Collaborative Transplant Study report Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk Higher CD19+CD25+ Bregs are independently associated with better graft function in renal transplant recipients Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients Functional Fc Gamma Receptor Gene Polymorphisms and Long-Term Kidney Allograft Survival Low pre-transplant caveolin-1 serum concentrations are associated with acute cellular tubulointerstitial rejection in kidney transplantation Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies Pre-transplant HLA antibodies and delayed graft function in the current era of kidney transplantation Association of C1q-fixing DSA with late graft failure in pediatric renal transplant recipients Donor-specific antibodies require preactivated immune system to harm renal transplant Role and Value of Luminex®-Detected HLA Antibodies before and after Kidney Transplantation Suppression der Alloimmunisation gegen Thrombozyten und Leukozyten durch Vorbehandlung mit Antikörper-bedeckten Zellen

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Caner Süsal

Risk of cellular or antibody-mediated rejection in pediatric kidney transplant recipients with BK polyomavirus replication—an international CERTAIN registry study

Incidence, risk factors, management strategies, and outcomes of antibody-mediated rejection in pediatric kidney transplant recipients—a multicenter analysis of the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN)

Maternal versus paternal living kidney transplant donation is associated with lower rejection in young pediatric recipients: A Collaborative Transplant Study report

Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk

Higher CD19+CD25+ Bregs are independently associated with better graft function in renal transplant recipients

Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients

Functional Fc Gamma Receptor Gene Polymorphisms and Long-Term Kidney Allograft Survival

Low pre-transplant caveolin-1 serum concentrations are associated with acute cellular tubulointerstitial rejection in kidney transplantation

Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies

Pre-transplant HLA antibodies and delayed graft function in the current era of kidney transplantation

Association of C1q-fixing DSA with late graft failure in pediatric renal transplant recipients

Donor-specific antibodies require preactivated immune system to harm renal transplant

Role and Value of Luminex®-Detected HLA Antibodies before and after Kidney Transplantation

Suppression der Alloimmunisation gegen Thrombozyten und Leukozyten durch Vorbehandlung mit Antikörper-bedeckten Zellen